Ramky Infrastructure Limited has submitted its certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 to stock exchanges for the quarter ended March 31, 2026. The submission confirms that details of securities dematerialized and rematerialized during Q4FY26 have been furnished to all stock exchanges where the company's shares are listed.

Q4FY26 Regulatory Compliance

The company submitted the compliance certificate on April 10, 2026, addressing both BSE Limited and National Stock Exchange of India Limited. The certificate covers the quarter ended March 31, 2026, and ensures adherence to depositories and participants regulations under SEBI framework.

KFin Technologies Certification

KFin Technologies Limited, serving as the company's registrar and share transfer agent, provided confirmation certificates to both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) on April 01, 2026. The certificates were signed by Rajitha Cholleti, Vice President at KFin Technologies Limited.

The registrar confirmed that all required details of securities dematerialized and rematerialized during the quarter have been properly furnished to stock exchanges as mandated under regulations.

Corporate Communication Framework

The submission was executed by N. Kesava Datta, Company Secretary (Membership No: A 61331), from the company's registered office at Ramky Grandiose, Gachibowli, Hyderabad. The communication was digitally signed and formally addressed to operations departments at both major Indian stock exchanges.

Regulatory Infrastructure

The compliance framework demonstrates the company's systematic approach to meeting SEBI requirements for depositories and participants regulations. KFin Technologies Limited maintains operations across key financial centers, ensuring comprehensive service delivery for share transfer and registry maintenance activities throughout the reporting period.

Ramky Infrastructure Limited has successfully executed a Share Purchase Agreement for the sale of its subsidiary Visakha Pharmacity Limited shares to Brij Gopal Construction Company Private Limited. The transaction, valued at ₹165.24 crores, was completed on March 30, 2026, following the board approval granted on March 28, 2026.

Transaction Execution and Financial Details

The company has received the full consideration amount of ₹165.24 crores for the transfer of 91,80,000 equity shares representing 51% stake in Visakha Pharmacity Limited. The share transfers will be completed within the timeframes specified in the Share Purchase Agreement.

Visakha Pharmacity Financial Performance Overview

Visakha Pharmacity Limited's contribution to Ramky Infrastructure's consolidated financials demonstrates the subsidiary's operational significance. The financial metrics highlight the subsidiary's performance during 2024-25.

Board Authorization and Regulatory Compliance

The board meeting held on March 28, 2026, from 05:45 PM to 06:15 PM, had previously authorized the Managing Director and Chief Financial Officer to finalize the Share Purchase Agreement terms. This transaction aligns with the approval accorded by company members through a postal ballot process initiated on December 27, 2023, with results declared on January 28, 2024.

Transaction Structure and Buyer Details

The sale involves transferring Ramky Infrastructure's entire 51% shareholding in Visakha Pharmacity Limited to Brij Gopal Construction Company Private Limited, which does not belong to the promoter group. The transaction is classified as a non-related party transaction and will be completed within 10 days from the SPA execution date.

Regulatory Disclosure Framework

Ramky Infrastructure has provided comprehensive disclosures under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 following the Share Purchase Agreement execution. The announcement was communicated to both NSE and BSE, signed by Company Secretary N. Kesava Datta, ensuring adherence to corporate governance standards and regulatory protocols.